@drdnjackson's MOTS-c cofactor claims need more evidence

What does this video actually claim?

Dr. Dwayne Jackson argues that MOTS-c, a mitochondrial peptide, won't work without specific cofactors like magnesium. He claims MOTS-c activates AMPK (a cellular energy sensor) and decreases with age, making it a longevity target.

The video cuts off mid-sentence while listing cofactors, but the premise is clear: you're wasting money on MOTS-c unless you add the right supplements. Jackson positions this as essential knowledge for anyone considering peptide therapy.

This represents the classic biohacker approach of stacking compounds for supposed synergistic effects.

Does the science actually support MOTS-c for longevity?

The research on MOTS-c is promising but extremely early. Most studies have been conducted in mice, not humans.

A 2015 study by Lee et al. in Cell Metabolism showed MOTS-c improved glucose homeostasis and protected against diet-induced obesity in mice. Subsequent research by Reynolds et al. (Nature Communications, 2021) found MOTS-c levels decline with age in humans and that the peptide can improve insulin sensitivity.

But here's the problem: we don't have long-term human trials proving MOTS-c extends lifespan or significantly improves metabolic health. The aging research is correlational, not causal.

The AMPK activation claim is accurate based on animal studies, but translating mouse longevity research to humans has a notoriously poor track record.

What about the cofactor requirement claims?

Jackson's cofactor claims are largely speculative. There's no published research specifically testing whether magnesium or other cofactors enhance MOTS-c effectiveness in humans.

While magnesium does play roles in mitochondrial function and ATP synthesis, the idea that you need specific cofactors to make MOTS-c work is unsupported by clinical evidence. This appears to be extrapolation from general mitochondrial biochemistry rather than MOTS-c-specific research.

The "you're wasting your money" framing is particularly problematic since we don't even have solid evidence that MOTS-c supplementation works reliably in humans in the first place. You might be wasting your money on the peptide itself, cofactors or not.

What are the real limitations here?

MOTS-c isn't approved by the FDA for any medical use. It's sold by compounding pharmacies and peptide suppliers in a regulatory gray area with minimal quality control.

We don't know the optimal dosing, long-term safety profile, or even whether exogenous MOTS-c effectively reaches mitochondria in humans. The bioavailability and pharmacokinetics are poorly understood.

Most concerning is that Jackson presents this information with scientific authority while glossing over these massive knowledge gaps. The research simply isn't mature enough to make confident recommendations about cofactor requirements.

If you're interested in mitochondrial health, established interventions like exercise, adequate sleep, and proper nutrition have far stronger evidence bases than experimental peptides.